$Amedisys (AMED.US)$Revenue continued to grow over the past ...

$Amedisys (AMED.US)$Revenue continued to grow over the past 5 years, with a growth rate of 0.41% in 2022 and an average growth rate of 8% for 5 years. Operating profit grew rapidly in the first 4 years, fell sharply by 27% in 2022, and net profit also fell sharply by 44% in 2022. The income statement shows that gross margin fell by 2.2% in 2022, and there was almost no increase in revenue, resulting in a 1.8% decline in gross profit, while expenses increased by 6.9%, causing a sharp decline in profit. In addition, there were other revenues of $38 million in 2021, which became a small amount of other expenses in 2022, which also contributed greatly to the decline in profits. Otherwise, net profit in 2021 would have stopped growing.